Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-26

Clinical Trial Update: Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated the efficacy of oral tofacitinib for moderate to severe alopecia areata, including alopecia totalis and universalis, complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tofacitinib (tofacitinib)

Snippet

Sponsor: Jinnah Hospital | Conditions: Alopecia Areata, Alopecia Totalis | Phase 3 | Status: COMPLETED